The study has enrolled 1,535 participants across 13 countries and is expected to be completed in early 2026, with topline results anticipated ahead of a potential FDA filing
Para ser atendido, basta mandar sua dvida no nosso WhatsApp: (11) 99999-0380
Peptide therapy requires deep medical knowledge and access to high-quality compounds, making it essential to choose a trusted clinic
In the Phase III LIBERTY-UC and LIBERTY-CD studies, Zymfentra elicited higher rates of clinical remission than placebo in patients with moderate-to-severe UC and CD, respectively, following induction with intravenous infliximab
This mechanism is where BPC truly shines in the healing process of soft tissue
In addition, researchers investigate its effects on nitric oxide pathways, epithelial stability, and cytokine balance across different experimental models